Clinical Research Directory
Browse clinical research sites, groups, and studies.
Thyroid Hormones in CKD
Sponsor: Mario Negri Institute for Pharmacological Research
Summary
This is a retrospective, observational, study evaluating circulating thyroid hormone profiles in patients with severe chronic kidney disease (CKD stages G4-G5, non-dialysis). The study includes one cohort of patients with non-ADPKD CKD and a second including a matched subset of patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) at the same CKD stage,. For the non-ADPKD CKD group, serum and urine samples will be retrieved from the certified biobank of the Centro Daccò (Mario Negri IRCCS). For the ADPKD group, analyses will be performed exclusively using existing clinical and laboratory data available within the REORIENTED study database. Laboratory measurements will be performed on stored biological samples from the non-ADPKD CKD group to assess thyroid hormones (rT3, fT3, tT3, fT4, tT4, and TSH). Clinical and laboratory data for both cohorts will be obtained from the respective study databases and linked within a predefined temporal window relative to sample collection (where applicable).
Official title: Deciphering the Role of Thyroid Hormones in Severe Non-ADPKD Chronic Kidney Disease
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
51
Start Date
2026-09
Completion Date
2027-09
Last Updated
2026-06-23
Healthy Volunteers
No
Conditions
Interventions
Laboratory measurements
Reverse T3 will be measured using a dedicated ELISA assay. Total T3, total T4, free T3, free T4, and TSH will be measured using chemiluminescent immunoassays according to the standard operating procedures of the Laboratory of Clinical Chemistry
Locations (1)
Clinical Research Centre for Rare Diseases Aldo e Cele Daccò
Ranica, BG, Italy